SFG
REGN icon

Strive Financial Group’s Regeneron Pharmaceuticals REGN Stock Holding History

Strive Financial Group’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.86K Buy
11
+1
+10% +$681 ﹤0.01% 494
2026
Q1 		$8K Hold
10
– – ﹤0.01% 450
2025
Q4 		$7.72K Buy
+10
New +$6.79K ﹤0.01% 419

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Strive Financial Group's REGN Position: Q2 2026 in Review

Strive Financial Group increased its Regeneron Pharmaceuticals (REGN) stake by 10% in Q2 2026, buying an estimated $681 and bringing the position to 11 shares worth $6.86K. The position accounts for ﹤0.01% of the portfolio, ranked #494.

Strive Financial Group first reported a position in REGN in Q4 2025 and has held it in 3 quarters since. The position peaked at $8K in Q1 2026. 1,330 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Strive Financial Group held 11 shares of Regeneron Pharmaceuticals worth $6.86K as of Q2 2026.
  • Strive Financial Group bought 1 Regeneron Pharmaceuticals share in Q2 2026, an estimated $681.
  • Regeneron Pharmaceuticals made up ﹤0.01% of Strive Financial Group's portfolio in Q2 2026, its #494 holding.
  • Strive Financial Group first reported a position in Regeneron Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • Strive Financial Group's Regeneron Pharmaceuticals position peaked at $8K in Q1 2026.
  • 1,330 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Strive Financial Group's 13F filing for Q2 2026, filed 4 Aug 2026.